Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis
- 1 March 2014
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 75, 211-221
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prevention of FGF-2-induced angiogenesis by scopoletin, a coumarin compound isolated from Erycibe obtusifolia Benth, and its mechanism of actionInternational Immunopharmacology, 2011
- Synthesis, and Antitumor Activity of Some N1-(Coumarin-7-yl) Amidrazones and Related CongenersMolecules, 2011
- Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathwaysVascular Pharmacology, 2011
- Dual Action of ATP Hydrolysis Couples Lid Closure to Substrate Release into the Group II Chaperonin ChamberCell, 2011
- Anti‐arthritic effect of scopoletin, a coumarin compound occurring in Erycibe obtusifolia Benth stems, is associated with decreased angiogenesis in synoviumFundamental & Clinical Pharmacology, 2010
- Cancer Epidemiology in the United States: Racial, Social, and Economic Factors2009
- Structural insights into hydroxycoumarin-induced apoptosis in U-937 cellsBioorganic & Medicinal Chemistry, 2008
- New cytotoxic agents: a review of the literatureCritical Reviews in Oncology/Hematology, 2005
- Simple Coumarins and Analogues in Medicinal Chemistry: Occurrence, Synthesis and Biological ActivityCurrent Medicinal Chemistry, 2005
- Suppression of 7,12-Dimethylbenz(α) Anthracene-Induced Breast Carcinoma by Coumarin in the RatOncology, 1976